Exelixis (EXEL) Gross Margin (QoQ) (2013 - 2026)

Exelixis (EXEL) Gross Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Exelixis 14.44 Bn 13.66 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 116.00
Jan 2, 2026 -132.00
Oct 3, 2025 32.00
Jul 4, 2025 3.00
Apr 4, 2025 7.00
Jan 3, 2025 -31.00
Sep 27, 2024 -44.00
Jun 28, 2024 223.00
Mar 29, 2024 -46.00
Dec 29, 2023 -56.00
Sep 29, 2023 -21.00
Jun 30, 2023 -27.00
Mar 31, 2023 25.00
Dec 30, 2022 -4.00
Sep 30, 2022 -50.00
Jul 1, 2022 49.00
Oct 1, 2021 25.00
Jul 2, 2021 102.00
Apr 2, 2021 19.00
Jan 1, 2021 -130.00